Abstract |
Castration-resistant prostate cancer (CRPC) has become a significant problem in the current treatment of prostate cancer (PCa) with the characteristics of high metastatic potential, resistance and easy recurrence. The abnormal activation of JAK2/STAT3/MCL-1 and NF-κB has been confirmed as the main reason for the development of CRPC. We previously found that β-elemonic acid (β-EA) as a natural triterpene has potential anti-inflammatory and anti- osteosarcoma effects with lower toxicity. But it remains unknown whether it had effects on CRPC. The present research in vitro and in vivo systematically investigates anti- cancer effects and mechanisms of β-EA on human CRPC. β-EA treatment resulted in apoptotic cell death in human PCa cells by mitochondrial apoptotic pathways (including up-regulation of cleaved caspase-3, cleaved PARP, and Bax or down-regulation of Bcl-2). Besides, β-EA at relatively lower levels inhibited colony-forming, the migration and invasion potential of PCa cells, indicating its anti-proliferation and anti- metastasis activities. After exploring the potential mechanism, our results suggested that it subsequently inhibited the activation of JAK2/STAT3/MCL-1 and NF-κB signaling pathway by the administration of β-EA. The silencing of NF-κB/p65, JAK2 and STAT3, respectively, increased the sensitivity of the PCa cells to β-EA induced apoptosis. Moreover, β-EA exhibited a strong affinity with its essential proteins JAK2, RELA/p65, NF-κBIα/IκBα by molecular docking analysis. Importantly, β-EA retards tumor growth in a murine xenograft model, consistent with our study in vitro. Taken together, findings from this study reveal for the first time the potential role and mechanisms of β-EA on CRPC.
|
Authors | Xiaowen Bao, Jianwei Zhu, Chaoxing Ren, Ang Zhao, Mingya Zhang, Zhiming Zhu, Xuanzhao Lu, Yuning Zhang, Xiaotian Li, Xinyu Sima, Jiaqi Li, Qi Zhang, Bo Ma |
Journal | Chemico-biological interactions
(Chem Biol Interact)
Vol. 342
Pg. 109477
(Jun 01 2021)
ISSN: 1872-7786 [Electronic] Ireland |
PMID | 33878321
(Publication Type: Journal Article)
|
Copyright | Copyright © 2021 Elsevier B.V. All rights reserved. |
Chemical References |
- Antineoplastic Agents
- MCL1 protein, human
- Myeloid Cell Leukemia Sequence 1 Protein
- NF-kappa B p50 Subunit
- NFKB1 protein, human
- STAT3 Transcription Factor
- STAT3 protein, human
- Triterpenes
- beta-elemonic acid
- JAK2 protein, human
- Janus Kinase 2
|
Topics |
- Animals
- Antineoplastic Agents
(pharmacology, therapeutic use)
- Apoptosis
(drug effects)
- Cell Line, Tumor
- Cell Proliferation
(drug effects)
- Humans
- Janus Kinase 2
(metabolism)
- Male
- Mice, Inbred BALB C
- Myeloid Cell Leukemia Sequence 1 Protein
(metabolism)
- NF-kappa B p50 Subunit
(metabolism)
- Prostatic Neoplasms, Castration-Resistant
(drug therapy)
- STAT3 Transcription Factor
(metabolism)
- Signal Transduction
(drug effects)
- Triterpenes
(pharmacology, therapeutic use)
- Xenograft Model Antitumor Assays
- Mice
|